title: Antihypertensive and vasodilator effect of A-80b, a new pyridazino indole derivative.
abstract: The hypotensive and antihypertensive activities of a A-80b, a newly synthesized pyridazino[4,5-b]indole derivate were investigated in anaesthetized rats. In vitro studies were also done to examine the possible mechanism of its vasodilator action. A 80b (3-15 mg/kg i.p.) showed potent and long-lasting antihypertensive activity in spontaneous hypertensive rats. In normotensive rats, A-80b (7.5-30 mg/kg i.p.) also lowered blood pressure but less than in hypertensive rats. The decrease in diastolic pressure was greater than the decrease in systolic pressure and cardiac frequency was not modified significantly. Contractile responses induced in isolated rat thoracic aorta by K+ and noradrenaline were inhibited by A-80b. In K(+)-depolarized rat aorta, A-80b showed dose-dependent inhibition of the Ca(2+)-induced contraction. Also, A-80b inhibited spontaneous contractions of rat portal vein. The vasodilator action seemed to be endothelium-independent. These results suggest that A-80b is a new chemical entity which exerts a hypotensive and antihypertensive effect, possibly attributable to vasodilator activity via interference with Ca2+ influx and probably Ca2+ mobilization from intracellular stores.
authors.affiliation: Department of Pharmacology, Universidad de Navarra, Pamplona, Spain.
authors.forename: D
authors.initials: D
authors.lastname: Frechilla
authors.forename: E
authors.initials: E
authors.lastname: Bernedo
authors.forename: E
authors.initials: E
authors.lastname: Castiella
authors.forename: B
authors.initials: B
authors.lastname: Lasheras
authors.forename: E
authors.initials: E
authors.lastname: Cenarruzabeitia
authors.forename: A
authors.initials: A
authors.lastname: Monge
authors.forename: I
authors.initials: I
authors.lastname: Aldana
authors.forename: T
authors.initials: T
authors.lastname: Alvarez
authors.forename: M J
authors.initials: MJ
authors.lastname: Losa
authors.forename: M
authors.initials: M
authors.lastname: Font
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001013:Aorta, Thoracic / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D004727:Endothelium / Q000502:physiology; D006830:Hydralazine / Q000008:administration & dosage / Q000494:pharmacology; D066298:In Vitro Techniques; D007211:Indoles / Q000008:administration & dosage / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D008297:Male; D011169:Portal Vein / Q000187:drug effects; D011724:Pyridazines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D011918:Rats, Inbred SHR; D017208:Rats, Wistar; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
chemical_list: D000959:Antihypertensive Agents; D007211:Indoles; D011724:Pyridazines; D014665:Vasodilator Agents; C077577:A 80b; D006830:Hydralazine